This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Neuropathy induced by antiviral nucleoside analogues

Authoring team

Peripheral neuropathy is not a feature of zidovudine but is seen in patients taking zalcitabine (ddC) and stavudine (D4T).

The peripheral neuropathy is characterised by:

  • paraesthesiae
  • areflexia
  • mild sensory loss
  • mild weakness

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.